REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2014 13F Holders as of 12/31/2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
160
Total 13F shares, excl. options
28.8M
Shares change
+1.26M
Total reported value, excl. options
$570M
Value change
+$24.9M
Put/Call ratio
0.33
Number of buys
71
Number of sells
-80
Price
$19.80

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2014

188 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2014.
REPLIGEN CORP - COMMON STOCK (RGEN) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.8M shares of 56.2M outstanding shares and own 51.21% of the company stock.
Largest 10 shareholders include FMR LLC (2.53M shares), BlackRock Fund Advisors (2.19M shares), Invesco Ltd. (1.73M shares), DIMENSIONAL FUND ADVISORS LP (1.34M shares), State Street Corp (1.32M shares), VANGUARD GROUP INC (1.19M shares), Conestoga Capital Advisors, LLC (1.13M shares), Ameriprise Financial Inc (1.05M shares), BlackRock Institutional Trust Company, N.A. (956K shares), and ACADIAN ASSET MANAGEMENT LLC (952K shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.